Literature DB >> 12741447

Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis.

Arnold L Barnett1, Pierre Y Crémieux.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741447     DOI: 10.1592/phco.23.5.690.32195

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  2 in total

1.  Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients.

Authors:  Roberto Minutolo; Piergiorgio Bolasco; Paolo Chiodini; Stefano Sposini; Maurizio Borzumati; Cataldo Abaterusso; Alessandra A Mele; Domenico Santoro; Valeria Canale; Alberto Santoboni; Oliviero Filiberti; Fulvio Fiorini; Carlo Mura; Patrizio Imperiali; Silvio Borrelli; Luigi Russo; Luca De Nicola; Domenico Russo
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

2.  Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability.

Authors:  Javier Arrieta; Iñigo Moina; José Molina; Isabel Gallardo; María Luisa Muñiz; Carmen Robledo; Oscar García; Fernando Vidaur; Rosa Inés Muñoz; Izaskun Iribar; Román Aguirre; Antonio Maza
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.